DLB — Dolby Laboratories Share Price
0.000.00%
Last trade - 00:00- $7.30bn
- $6.79bn
- $1.27bn
- 96
- 34
- 87
- 85
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 18.07 | ||
| PEG Ratio (f) | 1.09 | ||
| EPS Growth (f) | 19.91% | ||
| Dividend Yield (f) | 1.58% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.91 | ||
| Price to Tang. Book | 4.66 | ||
| Price to Free Cashflow | 18.49 | ||
| Price to Sales | 5.55 | ||
| EV to EBITDA | 19.28 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.01% | ||
| Return on Equity | 10.8% | ||
| Operating Margin | 20.68% | ||
Financial Summary
| Year End 27th Sep | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1,161.79 | 1,281.26 | 1,253.79 | 1,299.74 | 1,273.72 | 1,351.32 | 1,414.46 | 0.51% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -37.85 | +29.57 | -35.45 | +28.9 | +12.46 | +47.25 | +6.36 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Dolby Laboratories, Inc. is engaged in designing and manufacturing of audio and imaging hardware and software products for the cinema, television, broadcast and entertainment industries. The two primary components of its licensing business are Branded Technologies, which include Branded Audio Codecs, Dolby Atmos & Dolby Vision, and Patents, which include Audio Patents and Imaging Patents. The Company's cinema imaging products include digital cinema servers used to load, store, decrypt, decode, watermark, and playback digital film files for presentation on digital cinema projectors and software used to encrypt, encode and package digital media files for distribution. Its cinema audio products include cinema processors, amplifiers and loudspeakers used to decode, render, and optimally play back digital cinema soundtracks, including those using Dolby Atmos. It also offers various services to support theatrical and television production for cinema, broadcast, and home entertainment.
Directors
- Peter Gotcher NEC (62)
- Kevin Yeaman CEO (55)
- Robert Park CFO (51)
- Mark Sherman EVP (54)
- Todd Pendleton SVP (49)
- Giles Baker SVP (45)
- Steven Forshay SVP (67)
- Micheline Chau IND (68)
- David Dolby IND (44)
- Tony Prophet IND (62)
- Emily Rollins IND (51)
- Simon Segars IND (53)
- Roger Siboni IND (67)
- Anjali Sud IND (38)
- Avadis Tevanian IND (60)
- Last Annual
- September 27th, 2024
- Last Interim
- December 27th, 2024
- Incorporated
- September 1st, 2004
- Public Since
- February 17th, 2005
- No. of Shareholders
- 139
- No. of Employees
- 2,080
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- New York Stock Exchange
- Shares in Issue
- 96,377,077
- Address
- 1275 Market Street, SAN FRANCISCO, 94103
- Web
- https://www.dolby.com/
- Phone
- +1 4155580200
- Auditors
- KPMG LLP
Upcoming Events for DLB
Q2 2025 Dolby Laboratories Inc Earnings Call
Q3 2025 Dolby Laboratories Inc Earnings Release
Similar to DLB
A10 Networks
New York Stock Exchange
Accenture
New York Stock Exchange
ACV Auctions
New York Stock Exchange
Alibaba Holding
New York Stock Exchange
Alight
New York Stock Exchange
FAQ
What is the Dolby Laboratories share price?
As of Today at 20:17 UTC, shares in Dolby Laboratories are trading at $75.75. This share price information is delayed by 15 minutes.
How has the Dolby Laboratories share price performed this year?
Shares in Dolby Laboratories last closed at $75.75 and the price had moved by -5.21% over the past 365 days. In terms of relative price strength the Dolby Laboratories share price has underperformed the S&P500 Index by -12.5% over the past year.
What are the analyst and broker recommendations for Dolby Laboratories?
The overall consensus recommendation for Dolby Laboratories is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Dolby Laboratories dividend yield?
The Dolby Laboratories dividend yield is 1.62% based on the trailing twelve month period.
Does Dolby Laboratories pay a dividend?
Last year, Dolby Laboratories paid a total dividend of $1.23, and it currently has a trailing dividend yield of 1.62%. We do not have any data on when Dolby Laboratories is to next pay dividends.
When does Dolby Laboratories next pay dividends?
We do not have data on when Dolby Laboratories is to next pay dividends. The historic dividend yield on Dolby Laboratories shares is currently 1.62%.
How do I buy Dolby Laboratories shares?
To buy shares in Dolby Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Dolby Laboratories?
As of the previous close price of $75.75, shares in Dolby Laboratories had a market capitalisation of $7.30bn.
Where are Dolby Laboratories shares listed?
Here are the trading details for Dolby Laboratories:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: DLB
What kind of share is Dolby Laboratories?
Based on an overall assessment of its quality, value and momentum Dolby Laboratories is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Dolby Laboratories share price forecast for 2025?
The analyst consensus target price for shares in Dolby Laboratories is $100.00. That is 32.01% above the last closing price of $75.75.
Analysts covering Dolby Laboratories currently have a consensus Earnings Per Share (EPS) forecast of $4.04 for the next financial year.
Find out moreWhat is the trend in the Dolby Laboratories share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Dolby Laboratories. Over the past six months, its share price has outperformed the S&P500 Index by +9.69%.
As of the last closing price of $75.75, shares in Dolby Laboratories were trading -1.55% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Dolby Laboratories PE Ratio?
The Dolby Laboratories PE ratio based on its reported earnings over the past 12 months is 18.07. The shares last closed at $75.75.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Dolby Laboratories?
Dolby Laboratories' management team is headed by:
- Peter Gotcher - NEC
- Kevin Yeaman - CEO
- Robert Park - CFO
- Mark Sherman - EVP
- Todd Pendleton - SVP
- Giles Baker - SVP
- Steven Forshay - SVP
- Micheline Chau - IND
- David Dolby - IND
- Tony Prophet - IND
- Emily Rollins - IND
- Simon Segars - IND
- Roger Siboni - IND
- Anjali Sud - IND
- Avadis Tevanian - IND